118 related articles for article (PubMed ID: 4039084)
1. [Aminoglutethimide in the treatment of advanced prostatic cancer].
Bauer HW; Schmeller NT; Schmiedt E
Urologe A; 1985 Jan; 24(1):46-8. PubMed ID: 4039084
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment hormone levels in prostatic cancer.
Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
Scand J Urol Nephrol Suppl; 1988; 110():137-43. PubMed ID: 3187401
[TBL] [Abstract][Full Text] [Related]
3. [The effect of aminoglutethimide on steroid synthesis of the adrenal gland and its use in prostate cancer].
Knönagel H; Hauri D
Helv Chir Acta; 1989 Aug; 56(3):347-50. PubMed ID: 2807964
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biochemical effect of aminoglutethimide in the treatment of advanced prostatic carcinoma.
Worgul TJ; Santen RJ; Samojlik E; Veldhuis JD; Lipton A; Harvey HA; Drago JR; Rohner TJ
J Urol; 1983 Jan; 129(1):51-5. PubMed ID: 6827685
[TBL] [Abstract][Full Text] [Related]
5. Hypothyroidism associated with aminoglutethimide in patients with prostate cancer.
Figg WD; Thibault A; Sartor AO; Mays D; Headlee D; Calis KA; Cooper MR
Arch Intern Med; 1994 May; 154(9):1023-5. PubMed ID: 8179445
[TBL] [Abstract][Full Text] [Related]
6. The effects of endocrine therapy on plasma steroids in prostatic carcinoma patients.
Drafta D; Proca E; Schindler AE; Neacşu E; Zamfir V; Neagoe M; Teodosiu D
Endocrinologie; 1984; 22(3):191-7. PubMed ID: 6494786
[TBL] [Abstract][Full Text] [Related]
7. [Role of hormonal profile in adjusting therapy for prostate cancer].
Granov AM; Molchanov OE; Karelin MI
Vopr Onkol; 2008; 54(4):457-62. PubMed ID: 18942400
[TBL] [Abstract][Full Text] [Related]
8. Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone.
Ahmann FR; Crawford ED; Kreis W; Levasseur Y
Cancer Res; 1987 Sep; 47(17):4736-9. PubMed ID: 3621171
[TBL] [Abstract][Full Text] [Related]
9. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
Tomić R
Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040
[TBL] [Abstract][Full Text] [Related]
10. [Aspects for hormone therapy in prostate cancer].
Gorski J; Böhm WD; Kelly LU
Z Urol Nephrol; 1981 Sep; 74(9):635-41. PubMed ID: 7314984
[TBL] [Abstract][Full Text] [Related]
11. Aminoglutethimide in the treatment of advanced prostatic cancer.
Murray R; Pitt P
Prog Clin Biol Res; 1987; 243A():275-82. PubMed ID: 3658999
[No Abstract] [Full Text] [Related]
12. Hormonal pattern in prostatic cancer. II. Correlation with primary response to endocrine treatment.
Adlercreutz H; Rannikko S; Kairento AL; Karonen SL
Acta Endocrinol (Copenh); 1981 Dec; 98(4):634-40. PubMed ID: 7304086
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
[TBL] [Abstract][Full Text] [Related]
14. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
Labrie F; Dupont A; Belanger A; Lefebvre FA; Raynaud JP
J Pharmacol; 1983; 14 Suppl 3():117-35. PubMed ID: 6423907
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of aminoglutethimide in stage D prostate cancer: an assessment of efficacy and toxicity in patients with tumors refractory to hormonal therapy.
Block M; Trump D; Rose DP; Cummings KB; Hogan TF
Cancer Treat Rep; 1984 May; 68(5):719-22. PubMed ID: 6722829
[No Abstract] [Full Text] [Related]
16. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.
Morote J; Orsola A; Planas J; Trilla E; Raventós CX; Cecchini L; Catalán R
J Urol; 2007 Oct; 178(4 Pt 1):1290-5. PubMed ID: 17698136
[TBL] [Abstract][Full Text] [Related]
17. [Principles for the conservative drug therapy treatment of prostate cancer].
Hofmann W
Z Urol Nephrol; 1981 Sep; 74(9):697-704. PubMed ID: 7314992
[No Abstract] [Full Text] [Related]
18. Early results of the Finnish Multicentre Study of Prostatic Cancer (Finnprostate).
Haapiainen R; Rannikko S; Ruutu M; Ala-Opas M; Aro J; Ervasti J; Hansson E; Hurme K; Juusela H; Mäkinen J
Ann Chir Gynaecol; 1985; 74(6):277-83. PubMed ID: 4096480
[TBL] [Abstract][Full Text] [Related]
19. The role of somatostatin analogues in complete antiandrogen treatment in patients with prostatic carcinoma.
Vainas G; Pasaitou V; Galaktidou G; Maris K; Christodoulou K; Constantinidis C; Kortsaris AH
J Exp Clin Cancer Res; 1997 Mar; 16(1):119-26. PubMed ID: 9148872
[TBL] [Abstract][Full Text] [Related]
20. Aminoglutethimide in advanced prostatic carcinoma.
Harnett PR; Raghavan D; Caterson I; Pearson B; Watt H; Teriana N; Coates A; Coorey G
Br J Urol; 1987 Apr; 59(4):323-7. PubMed ID: 3555688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
